Researchers Identify Gene Associated with Cervical Dystonia
Researchers Identify Gene Associated with Primary Cervical Dystonia
Research
Feinstein Scientists Identify Abnormal Disease Pathway in Dystonia
Manhasset, NY (Vocus/PRWEB)
A team of scientists at The Feinstein Institute for Medical Research have figured out why some people with a gene that causes dystonia never get symptoms and others with the same mutation are disabled by the abnormal movements. More
For potentially crippling dystonia, earlier deep brain therapy gets better, quicker results
Las Angeles: Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology. More
Movement disorder symptoms are lessened by an antibiotic
Treating worms with ampicillin helps restore normal movement
TUSCALOOSA, Ala. – Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal Disease Models & Mechanisms.
"It's our hope that this discovery serves as the impetus for a proper clinical trial to evaluate the potential of drugs like ampicillin for early-onset torsion dystonia," said Dr. Guy Caldwell, associate professor of biological sciences at The University of Alabama.
Dr. Robert Chen Recipient of DMRF Research Grant
Robert Chen, MA, MBBChir, MSc, FRCPC , Toronto Western Hospital has been awarded a two year research grant through the DMRF research program.
Title: Effects of internal globus pallidus deep brain stimulation for dystonia on cortical circuits and plasticity.
Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
February 1, 2009 - A study led by Laurie Ozelius, PhD at Mount Sinai School of Medicine has identified a gene associated with the development of primary torsion dystonia, also known as DYT6 dystonia. More...
Abnormal Brain Circuits May Prevent Movement Disorder
physorg.com, Specific changes in brain pathways may counteract genetic mutations for the movement disorder dystonia, according to new research in the August 5 issue of The Journal of Neuroscience. Few people who inherit dystonia genes display symptoms -- namely sustained muscle contractions and involuntary gestures -- and the study provides a possible explanation. This result could lead to new treatments for the estimated 500,000 North Americans diagnosed with dystonia.
New XEOMIN® – Available in Canada
Press Release
New XEOMIN® – The First Botulinum Neurotoxin Type A That Is Free From Complexing Proteins – Is Now Available. Indicated For The Treatment of Blepharospasm, Cervical Dystonia* and Post-Stroke Spasticity.
HEALTH CHARITIES APPLAUD GOVERNMENT OF CANADA’S RESEARCH INVESTMENT IN NEUROLOGICAL CONDITIONS
TORONTO – Canadians with neurological conditions, caregivers and representatives from Neurological Health Charities Canada celebrate the announcement of $15 million in research funding, made today by The Honourable Leona Aglukkaq, Canada’s Minister of Health. The investment will fund the first-ever national study on the prevalence and impact of neurological diseases in Canada.
Updates on 2007 Research Grants
Several DMRF grants were completed in 2007. Here are brief updates on the results of two of these investigations.